Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aprea Therapeutics Inc (NQ: APRE )

4.070 -0.050 (-1.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 356,158
Open 4.090
Bid (Size) 4.080 (2)
Ask (Size) 4.110 (9)
Prev. Close 4.120
Today's Range 4.050 - 4.270
52wk Range 4.000 - 41.12
Shares Outstanding 21,186,827
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations
From GlobeNewswire News Releases
Aprea Therapeutics to Host Virtual R&D Day on April 22, 2021
From GlobeNewswire News Releases

Performance

YTD
-13.95%
-13.95%
1 Month
-7.92%
-7.92%
3 Month
-50.06%
-50.06%
6 Month
-80.54%
-80.54%
1 Year
-88.40%
-88.40%

More News

Read More
Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
From GlobeNewswire News Releases
Noteworthy Thursday Option Activity: HD, SRCL, APRE
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Thursday's Intraday Session
Tags BZI/TFM FBIO Market News
From Benzinga
What's Going On With APRE Stock And IMMP Stock Today?
Tags Benzinga IMMP Movers
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tags ECOR UPC Movers
From Benzinga
First Week of APRE May 21st Options Trading
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Tags Pre/Market Outlook Small Cap AMZN
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tags OPT AUPH News
From Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Tags SLNO FLDM OYST
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.